Regeneron Pharma's (REGN) Price Target Raised to $720 at Deutsche Bank
Tweet Send to a Friend
Deutsche Bank maintained a Buy rating on Regeneron Pharma (NASDAQ: REGN) and raised its price target to $720.00 (from $650.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
